TD Asset Management »

Hemab Therapeutics Holdings shares owned by TD Asset Management

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 33k 36.73

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Cibc Cad (CM)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Enbridge (ENB)
Amazon (AMZN)
Manulife Finl Corp (MFC)
Canadian Pacific Kansas City (CP)
Johnson & Johnson (JNJ)

View all positions for TD Asset Management

Top funds holding Hemab Therapeutics Holdings

Standard Life Aberdeen
TD Asset Management
China Universal Asset Management

View all funds holding Hemab Therapeutics Holdings